← All brands
Health & beauty
RevvoMed Innovations AB

RevvoMed

Maps proteins on the surface of cells in diseased and healthy tissue to find new cancer drug targets.

Stockholm, Sweden. Founded in 2025 by Nina Schiller (CEO), Christian Schiller and Robin Löving.

Started operations on 10 November 2026 after a 7 million kronor pre-seed round.

Written by our editors from public sources, linked in our story. Not a paid placement. Founders can request a correction.